Processa Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell PCSA and other ETFs, options, and stocks.About PCSA
Processa Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of drug products for the treatment of serious medical conditions. Its main product candidate is PCS499, which is intended for the treatment of Necrobiosis Lipoidica.
CEOGeorge K. Ng
CEOGeorge K. Ng
Employees10
Employees10
HeadquartersVero Beach, Florida
HeadquartersVero Beach, Florida
Founded2011
Founded2011
Employees10
Employees10
PCSA Key Statistics
Market cap15.33M
Market cap15.33M
Price-Earnings ratio-0.20
Price-Earnings ratio-0.20
Dividend yield—
Dividend yield—
Average volume1.05M
Average volume1.05M
High today$0.2878
High today$0.2878
Low today$0.2627
Low today$0.2627
Open price$0.27
Open price$0.27
Volume1.56M
Volume1.56M
52 Week high$1.50
52 Week high$1.50
52 Week low$0.15
52 Week low$0.15
Stock Snapshot
The current Processa Pharmaceuticals(PCSA) stock price is $0.28, with a market capitalization of 15.33M. The stock trades at a price-to-earnings (P/E) ratio of -0.20.
As of 2025-12-05, Processa Pharmaceuticals(PCSA) stock has fluctuated between $0.26 and $0.29. The current price stands at $0.28, placing the stock +4.7% above today's low and -4.4% off the high.
Processa Pharmaceuticals(PCSA) shares are trading with a volume of 1.56M, against a daily average of 1.05M.
During the past year, Processa Pharmaceuticals(PCSA) stock moved between $0.15 at its lowest and $1.50 at its peak.
During the past year, Processa Pharmaceuticals(PCSA) stock moved between $0.15 at its lowest and $1.50 at its peak.
People also own
Based on the portfolios of people who own PCSA. This list is generated using Robinhood data, and it’s not a recommendation.